Health
Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA
ROCKVILLIE, MD. and SUZHOU, China, Feb. 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major di...
2024-02-20 08:22
3951
HKUST Neuroscientists Develop Highly Accurate Universal Diagnostic Blood Test for Alzheimer's Disease and Mild Cognitive Impairment
At a glance: * Remarkably high accuracy rate – over 96% for AD and 87% for MCI; * Applicable across diverse ethnic populations, including Chinese and European; * Enables early detection of AD and subsequent progression; * Captures multiple AD-associated biological pathways; * A game-chan...
2024-02-19 20:18
2030
SIBIONICS Announced to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
The company will be hosting an influencer meeting during the conference LOS ANGELES, Feb. 19, 2024 /PRNewswire/ -- SIBIONICS, the world's third-largest Continuous Glucose Monitoring (CGM) System brand, announced the company will be exhibiting at the International Fair of New Technologies in Diab...
2024-02-19 10:55
2209
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis
SHANGHAI, Feb. 19, 2024 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative pharmaceutical, and surgical products that address critical unmet medical needs in ophthalmology, today announced that the Singapore Health ...
2024-02-19 09:00
3538
Everest Medicines Announces Termination of Collaboration Agreements with Providence
-Everest will continue to develop self-discovered products utilizing the mRNA platform- SHANGHAI, Feb. 19, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative...
2024-02-19 08:20
2067
SwiftMR™, Game-Changing AI-Powered MRI Solution Gears Up in ANZ Market: AIRS Medical Forges Strategic Partnership with ParagonCare
SEOUL, South Korea, Feb. 19, 2024 /PRNewswire/ -- AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited(ASX: PGC), a premier provider of healthcare technology, devices, software, and consumables inAustral...
2024-02-19 06:00
2146
IFPA Releases an Innovative Psoriatic Care Roadmap and Action Playbook
STOCKHOLM, Feb. 16, 2024 /PRNewswire/ -- IFPA Forum Asia 2023, held in Singapore , brought together a diverse group of stakeholders, including patient advocates, their associations, family members, policymakers, healthcare professionals, and the private sector. Held inSingapore, the forum served a...
2024-02-16 17:00
7749
4 WAYS THE BEEM BY START UP MUDO LABS ON KICKSTARTER WILL REVOLUTIONIZE THE WAY YOU MASTER YOUR MOOD
The pocket-sized device lets you enhance a given mood through acupressure and aromachology SINGAPORE, Feb. 16, 2024 /PRNewswire/ -- Here's a reality check: stress levels in the workplace have reached an all-time high. According to the Global Workplace 2021 Report, 43 percent of respondents in ov...
2024-02-16 16:12
782
Planetree's Person-Centered Care Certification Standards Achieve International Recognition for Quality
DERBY, Conn., Feb. 15, 2024 /PRNewswire/ -- Planetree's Person-Centered Care Certification® standards have been recognized by the International Society for Quality in Health Care's External Evaluation Association (ISQua EEA). This marks the first time a set of quality standards for person-centere...
2024-02-15 23:00
1728
Kim Byoung Joon LEDAS Varicose Vein Clinic Becomes the First Organization to be Accredited under GHA Standards for Medical Travel 5.0
PALM BEACH GARDENS, Fla., Feb. 15, 2024 /PRNewswire/ -- In a significant achievement that firmly underscores its commitment to the highest standards of healthcare, Kim Byoung Joon LEDAS Varicose Vein Clinic ( https://www.kbjledas.com/) in Busan, South Korea, has been awarded the distinguished Acc...
2024-02-15 19:00
2164
Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED.
CASTRES, France and GENEVA, Feb. 15, 2024 /PRNewswire/ -- On February 20, International Ectodermal Dysplasias Awareness Day, Pierre Fabre Laboratories and the EspeRare Foundation will receive the EURORDIS Company Award for Patient Engagement 2024, at the EURORDIS Black Pearl Award Ceremony to be ...
2024-02-15 17:05
2092
Pharus Diagnostics Signs Worldwide Exclusive License Agreement with City of Hope for Novel Biomarkers to Be Used in Liquid Biopsy Screening for Early Pancreatic Cancer Diagnosis
LOS ANGELES, Feb. 15, 2024 /PRNewswire/ -- Pharus Diagnostics ("PharusDx") today announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be used in early screening of individuals at risk for pancreatic ductal adenocarcinoma (PDAC). This license...
2024-02-15 16:05
2123
Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate Technology Transfer to Expand Clinical and Commercial Supplies
Acquiring all intellectual properties relating to BRII-179 and eliminating future milestone and royalty payments to VBI, subject to achievement of certain activities Transferring manufacturing technologies of BRII-179 and PreHevbrio/PreHevbri to additional manufacturing sites and expanding footp...
2024-02-14 08:07
4159
Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³
Strong CSL Behring portfolio growth especially Ig FINANCIAL HIGHLIGHTS4 * Revenue $8.05 billion, up 11% at CC3 * NPAT $1.90 billion1, up 17% * NPAT $1.94 billion1 at CC3, up 20% * NPATA $2.02 billion1,2 , up 11% * NPATA $2.06 billion1,2 at CC3, up 13% * NPATA1,2 earnings per share $4.1...
2024-02-13 14:21
4132
Medical Tourism Patient Survey 2024 Shares Deep Insights into Barriers to Patient Acquisition
WEST PALM BEACH, Fla., Feb. 13, 2024 /PRNewswire/ -- The Medical Tourism Association (MTA) has recently released theMedical Tourism Patient Survey 2024, which provides invaluable insights into the motivations behind healthcare consumers' medical travel decisions and the barriers to patient inflow...
2024-02-13 06:47
2082
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.
VANCOUVER, BC, Feb. 13, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has executed the definitive Asset Purchase Agreement datedFebruary 11th, 2024 to acquire the entire portfolio of discovery, preclinical and cli...
2024-02-13 03:26
4193
CeraVe Collaborates with Michael Cera and TikTok Stars on First-of-its-Kind Global Campaign
#1 Gen Z skincare brand in the U.S. goes big with hilarious campaign reinforcing CeraVe is developed with dermatologists notMichael Cera. NEW YORK, Feb. 12, 2024 /PRNewswire/ -- CeraVe, the #1 dermatologist-recommended skincare brand in the US, has revealed the epic conclusion to its inaugural S...
2024-02-12 21:23
2971
Frost & Sullivan Recognizes Innovaccer for Enabling Value-Based Care with Its AI and Advanced Analytics
Innovaccer's AI-powered VBC solution suite unifies patient data seamlessly across diverse systems and care settings, empowering healthcare organizations with innovative, scalable applications. SAN ANTONIO, Feb. 12, 2024 /PRNewswire/ -- After evaluating the revenue cycle management (RCM) industry...
2024-02-12 21:00
1938
DigniCap Delta receives market approval in Japan
LUND, Sweden, Feb. 12, 2024 /PRNewswire/ -- Dignitana announces that DigniCap Delta received market approval inJapan from the Ministry of Health, Labor and Welfare (MHLW). In Japan, Dignitana will provide DigniCap Delta to Konica Minolta as a medical device manufacturer, and Konica Minolta will p...
2024-02-12 16:40
2146
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
* Initial research project is with NDORMS, Botnar Research Institute, University of Oxford, focusing on accelerated aging in space * Dr. James L. Green, former Chief Scientist of NASA and Dr. Tara Ruttley, former Associate Chief Scientist of NASA to join Prenetics Scientific Advisory Board ...
2024-02-09 22:44
3143
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8288
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7685